Regenerative Patch Technologies LLC (RPT) is a CA-based biotechnology company focused on the development of stem cell-based therapies designed to reverse blindness caused by advanced dry age related macular degeneration (AMD).
| Website | http://regenerativepatch.com |
| Revenue | $6 million |
| Employees | 9 (5 on RocketReach) |
| Founded | 2010 |
| Address | 650 Page Mill Rd, Palo Alto, California 94304, US |
| Phone | (650) 394-5835 |
| Industry | Biotechnology Research, Business Services General, Biotechnology, Drug Discovery, Business Services, Science and Engineering |
| Keywords | Macular Degeneration Treatment, Stem Cell Therapy, Vision Restoration, Regenerative Medicine, Blindness Treatment, Age Related Macular Degeneration, Cell Based Therapy, Eye Disease Treatment, Biotechnology |
| Competitors | Smith+Nephew, Integra LifeSciences, Medtronic, Acelity, MiMedx, Organogenesis, Kerecis, Sientra, Inc., Regenicin, Amniox +28 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies |
Looking for a particular Regenerative Patch Technologies employee's phone or email?
The Regenerative Patch Technologies annual revenue was $6 million in 2026.
Dennis Clegg is the Co-Founder of Regenerative Patch Technologies.
5 people are employed at Regenerative Patch Technologies.
Regenerative Patch Technologies is based in Palo Alto, California.
The NAICS codes for Regenerative Patch Technologies are [541, 54, 5417].
The SIC codes for Regenerative Patch Technologies are [873, 87].